Back to Miscellaneous News
Oblon Spivak Leading Post-Grant Patent Practice Expands Life Sciences Depth
Tuesday, June 17, 2014
Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. is pleased to announce that Dianna DeVore, Ph.D. has joined the firm’s the Post-Grant Patent practice group as Special Counsel.
Dr. DeVore brings over 18 years’ experience in intellectual property and transactional law, including providing product protection strategies and coordinating adversarial proceedings for companies ranging from emerging technology companies to large pharmaceutical companies.
Prior to joining Oblon Spivak, Devore was Vice President of Intellectual Property and Legal Affairs at Ariosa Diagnostics, Inc. where she developed a coordinated intellectual property strategy including post-grant challenges, litigation, and related patent prosecution. Dianna holds a J.D. from Stanford Law School, a Ph.D. in Genetics from Yale University.
“Dr. Devore has been in the trenches on Bio/Pharma IPRs since day one. Under her lead, the filings of Ariosa Diagnostics have blazed the trail now followed by many companies in this critical tech space. We are thrilled to consistently attract such high-level talent to our post grant practice group” said Scott McKeown, Co-chair of Oblon Spivak’s Post-Grant Patent Practice Group.
Assisting clients for over 40 years, Oblon Spivak is one of the largest intellectual property specialty firms in the United States. The firm provides a full range of intellectual property services and is the recognized leader in patent prosecution and post-grant trials before the USPTO’s Patent Trial & Appeal Board. The firm also represents their clients in all forms of intellectual property litigation, including trademark, copyright and trade dress disputes.
Back to Miscellaneous News
